Haemoglobin D disease (Q39526): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Doença da hemoglobina D (Hb D) é caracterizada por anemia hemolítica leve e esplenomegalia leve a moderada. A prevalência é desconhecida. As formas heterozigotas da Hb D são clinicamente silenciosas. Testes moleculares podem ser úteis para distinguir a homozigose para Hb D de casos de Hb D heterozigótica em associação com beta-(0) talassemia | |||
| description / en | description / en | ||
Haemoglobin D (Hb D) disease is characterised by mild haemolytic anaemia and mild to moderate splenomegaly. Prevalence is unknown. Heterozygous forms of Hb D are clinically silent. Molecular testing can be useful to distinguish Hb D homozygosity from cases of heterozygous Hb D in association with beta-(0) thalassaemia. | |||
Revision as of 04:58, 13 August 2026
Haemoglobin D (Hb D) disease is characterised by mild haemolytic anaemia and mild to moderate splenomegaly. Prevalence is unknown. Heterozygous forms of Hb D are clinically silent. Molecular testing can be useful to distinguish Hb D homozygosity from cases of heterozygous Hb D in association with beta-(0) thalassaemia.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 3A51.6 |
||
| English | Haemoglobin D disease |
Haemoglobin D (Hb D) disease is characterised by mild haemolytic anaemia and mild to moderate splenomegaly. Prevalence is unknown. Heterozygous forms of Hb D are clinically silent. Molecular testing can be useful to distinguish Hb D homozygosity from cases of heterozygous Hb D in association with beta-(0) thalassaemia. |
